Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Eman ElZahaf"'
Publikováno v:
The Egyptian Journal of Internal Medicine, Vol 35, Iss 1, Pp 1-13 (2023)
Abstract Background Hepatocellular carcinoma represents 85%—90% of primary liver tumors; it represents the 2nd leading cause of cancer-related death all over the world. There is a growing incidence of HCC worldwide and similarly, the incidence of H
Externí odkaz:
https://doaj.org/article/6659c411e597470ab2255a9bb6b36ef2
Autor:
Mohammad Arafa, Abdelhadi Mohamed Shebl, Amany Salama, Eman ElZahaf, Sylvia A. Ashamallah, Abd AlRahman Foda, AzmyAbd El-Hameed Awad, Asem Shalaby
Publikováno v:
European Journal of Obstetrics & Gynecology and Reproductive Biology: X, Vol 16, Iss , Pp 100172- (2022)
Background: Endometrial carcinoma (EC) is the most common gynaecological cancer worldwide. The Cancer Genome Atlas molecular grouping of a given case of EC could be assessed by POLE gene mutation, mismatch repair (MMR) ‘to reflect microsatellite in
Externí odkaz:
https://doaj.org/article/9389c654076b4abda8f15f33c0e0c058
Potential Role for a Panel of Immunohistochemical Markers in the Management of Endometrial Carcinoma
Autor:
Amany Salama, Mohammad Arafa, Eman ElZahaf, Abdelhadi Mohamed Shebl, Azmy Abd El-Hameed Awad, Sylvia A. Ashamallah, Reda Hemida, Anas Gamal, Abd AlRahman Foda, Khaled Zalata, El-Said M. Abdel-Hady
Publikováno v:
Journal of Pathology and Translational Medicine, Vol 53, Iss 3, Pp 164-172 (2019)
Background In order to improve the efficacy of endometrial carcinoma (EC) treatment, identifying prognostic factors for high risk patients is a high research priority. This study aimed to assess the relationships among the expression of estrogen rece
Externí odkaz:
https://doaj.org/article/2427c6a383c34e29932199dd6abb6b01
Publikováno v:
Research in Oncology. 4:67-73
Autor:
Eman Elzahaf, Rasha Hamdy Hamed
Publikováno v:
Journal of Cancer Science & Therapy.
Purpose: The purpose of this prospective phase III study was to compare the role of concomitant chemoradiation using paclitaxel versus cisplatin in locally advanced head and neck cancers. Patients and methods: 52 patients were randomly assigned to on
Autor:
Eman Elzahaf, Maha AbdAlla, Hala Abdel Malek, Doaa Sharaf Eldin, Amany Mohamed Shalaby, Nashat Noman, Waleed Eldars, Mohamed Ahdy A A Saad, Ashraf Shoma, Dalia Zayed
Publikováno v:
Current clinical pharmacology. 5(4)
Introduction: Breast-conserving therapy is currently the standard of management of breast cancer cases. Radiotherapy is an integral part of it; however, it has several complications. Radiation induced burn is a common complication of radiotherapy tha